JPM – Dealmaking in 2022: What’s Big Pharma looking for and what is it willing to pay?

John Carroll:

Okay, well, thanks everybody for coming out today. We had a ton of registrations for this panel discussion about dealmaking in 2022. I think that every year is a big year when it comes to dealmaking, M&A, and business development deals. And we’re certainly seeing a lot...

Click to view original post